E. Abraham and E. Chain, An Enzyme from Bacteria able to Destroy Penicillin, Nature, vol.146, issue.3713, pp.677-685, 1940.
DOI : 10.1038/146837a0

F. Saliba, A. Carbonne, S. Neuville, D. Decre, and C. Sengelin, Paris: Haut Conseil de la Santé Publique; 2013 juill [cité 9 mai 2016] Disponible sur: http://www.hcsp.fr/explore.cgi/avisrapportsdomaine?clefr=372 3 Extended measures for controlling an outbreak of VIM-1 producing imipenem-resistant Klebsiella pneumoniae in a liver, HCSP. Prévention de la transmission croisée des « Bactéries Hautement Résistantes aux antibiotiques émergentes, 2003.

S. Vaux, A. Carbonne, J. Thiolet, V. Jarlier, and B. Coignard, RAISIN and Expert Laboratories Groups. Emergence of carbapenemase-producing Enterobacteriaceae in France, Euro Surveill Bull Eur Sur Mal Transm Eur Commun Dis Bull, vol.16, issue.22, 2004.

J. Desenclos, . Raisin-working, and . Group, RAISIN -a national programme for early warning, investigation and surveillance of healthcare-associated infection in France, Euro Surveill Bull Eur Sur Mal Transm Eur Commun Dis Bull, vol.14, issue.46, 2009.
URL : https://hal.archives-ouvertes.fr/hal-00448364

E. Lesho, R. Clifford, U. Chukwuma, Y. Kwak, M. Maneval et al., Carbapenem-resistant Enterobacteriaceae and the correlation between carbapenem and fluoroquinolone usage and resistance in the US military health system, Diagnostic Microbiology and Infectious Disease, vol.81, issue.2, pp.119-144, 2015.
DOI : 10.1016/j.diagmicrobio.2014.09.017

S. Fournier, M. Lepainteur, N. Kassis-chikhani, M. Huang, C. Brun-buisson et al., Carriage and Cross???Border Exchanges: Eight???Year Surveillance in a Large French Multihospitals Institution, Journal of Travel Medicine, vol.19, issue.5, pp.320-323, 2012.
DOI : 10.1111/j.1708-8305.2012.00641.x

P. Nordmann and L. Poirel, The difficult-to-control spread of carbapenemase producers among Enterobacteriaceae worldwide, Clinical Microbiology and Infection, vol.20, issue.9, pp.821-851, 2014.
DOI : 10.1111/1469-0691.12719

A. Queenan and K. Bush, Carbapenemases: the versatile beta-lactamases, 440?458, table of contents, 2007.
DOI : 10.1128/cmr.00001-07

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1932750

M. Dautzenberg, A. Wekesa, M. Gniadkowski, A. Antoniadou, H. Giamarellou et al., The Association Between Colonization With Carbapenemase-Producing Enterobacteriaceae and Overall ICU Mortality, Critical Care Medicine, vol.43, issue.6, pp.1170-1177, 2015.
DOI : 10.1097/CCM.0000000000001028

A. Medeiros, ??-LACTAMASES, British Medical Bulletin, vol.40, issue.1, pp.18-27, 1984.
DOI : 10.1093/oxfordjournals.bmb.a071942

J. Patterson, Extended-Spectrum Beta-Lactamases, Seminars in Respiratory and Critical Care Medicine, vol.24, issue.1, pp.79-88, 2003.
DOI : 10.1055/s-2003-37919

R. Cantón and T. Coque, The CTX-M ??-lactamase pandemic, Current Opinion in Microbiology, vol.9, issue.5, pp.466-75, 2006.
DOI : 10.1016/j.mib.2006.08.011

J. Zahar, O. Lortholary, C. Martin, G. Potel, P. Plesiat et al., Addressing the challenge of extended-spectrum beta-lactamases, Curr Opin Investig Drugs Lond Engl févr, vol.10, issue.2, pp.172-80, 2000.
URL : https://hal.archives-ouvertes.fr/hal-00464775

R. Gauzit, Recommandations de bon usage des carbap??n??mes, Antibiotiques, vol.12, issue.4, 2010.
DOI : 10.1016/j.antib.2010.09.002

L. Martínez-martínez, Extended-spectrum beta-lactamases and the permeability barrier, Clin Microbiol Infect Off Publ Eur Soc Clin Microbiol Infect Dis. janv, vol.14, issue.1, pp.82-91, 2008.

H. Yigit, A. Queenan, G. Anderson, A. Domenech-sanchez, J. Biddle et al., Novel Carbapenem-Hydrolyzing ??-Lactamase, KPC-1, from a Carbapenem-Resistant Strain of Klebsiella pneumoniae, Antimicrobial Agents and Chemotherapy, vol.45, issue.4, pp.1151-61, 2001.
DOI : 10.1128/AAC.45.4.1151-1161.2001

P. Giakkoupi, L. Tzouvelekis, A. Tsakris, V. Loukova, D. Sofianou et al., IBC-1, a Novel Integron-Associated Class A beta -Lactamase with Extended-Spectrum Properties Produced by an Enterobacter cloacae Clinical Strain, Antimicrobial Agents and Chemotherapy, vol.44, issue.9, pp.2247-53, 2000.
DOI : 10.1128/AAC.44.9.2247-2253.2000

L. Poirel, L. Thomas, I. Naas, T. Karim, A. Nordmann et al., Biochemical Sequence Analyses of GES-1, a Novel Class A Extended-Spectrum beta -Lactamase, and the Class 1 Integron In52 from Klebsiella pneumoniae, Antimicrobial Agents and Chemotherapy, vol.44, issue.3, pp.622-654, 2000.
DOI : 10.1128/AAC.44.3.622-632.2000

C. Bebrone, Metallo-??-lactamases (classification, activity, genetic organization, structure, zinc coordination) and their superfamily, Biochemical Pharmacology, vol.74, issue.12, pp.1686-701, 2007.
DOI : 10.1016/j.bcp.2007.05.021

R. Paton, R. Miles, J. Hood, S. Amyes, R. Miles et al., ARI 1: ??-lactamase-mediated imipenem resistance in Acinetobacter baumannii, International Journal of Antimicrobial Agents, vol.2, issue.2, pp.81-88, 1993.
DOI : 10.1016/0924-8579(93)90045-7

L. Poirel, C. Héritier, V. Tolün, and P. Nordmann, Emergence of Oxacillinase-Mediated Resistance to Imipenem in Klebsiella pneumoniae, Antimicrobial Agents and Chemotherapy, vol.48, issue.1, pp.15-22, 2004.
DOI : 10.1128/AAC.48.1.15-22.2004

D. Gülmez, N. Woodford, M. Palepou, S. Mushtaq, G. Metan et al., Carbapenem-resistant Escherichia coli and Klebsiella pneumoniae isolates from Turkey with OXA-48-like carbapenemases and outer membrane protein loss, International Journal of Antimicrobial Agents, vol.31, issue.6, pp.523-529, 2008.
DOI : 10.1016/j.ijantimicag.2008.01.017

L. Poirel, C. Héritier, and P. Nordmann, Chromosome-Encoded Ambler Class D ??-Lactamase of Shewanella oneidensis as a Progenitor of Carbapenem-Hydrolyzing Oxacillinase, Antimicrobial Agents and Chemotherapy, vol.48, issue.1, pp.348-51, 2004.
DOI : 10.1128/AAC.48.1.348-351.2004

L. Dortet, G. Cuzon, and P. Nordmann, détection des souches d'entérobactéries productrices d'une carbapénèmase

L. Dortet, L. Bréchard, L. Poirel, and P. Nordmann, Rapid detection of carbapenemase-producing Enterobacteriaceae from blood cultures, Clinical Microbiology and Infection, vol.20, issue.4, pp.340-344, 2014.
DOI : 10.1111/1469-0691.12318

L. Dortet, L. Poirel, and P. Nordmann, Rapid Identification of Carbapenemase Types in Enterobacteriaceae and Pseudomonas spp. by Using a Biochemical Test, Antimicrobial Agents and Chemotherapy, vol.56, issue.12, pp.6437-6477, 2012.
DOI : 10.1128/AAC.01395-12

K. Day, S. Ali, I. Mirza, H. Sidjabat, A. Silvey et al., Prevalence and molecular characterization of Enterobacteriaceae producing NDM-1 carbapenemase at a military hospital in Pakistan and evaluation of two chromogenic media, Diagnostic Microbiology and Infectious Disease, vol.75, issue.2, pp.187-91, 2013.
DOI : 10.1016/j.diagmicrobio.2012.11.006

K. Day, M. Salman, B. Kazi, H. Sidjabat, A. Silvey et al., Prevalence of NDM-1 carbapenemase in patients with diarrhoea in Pakistan and evaluation of two chromogenic culture media, Journal of Applied Microbiology, vol.50, issue.3, pp.1810-1816, 2013.
DOI : 10.1111/jam.12171

L. Poirel, A. Potron, and P. Nordmann, OXA-48-like carbapenemases: the phantom menace, Journal of Antimicrobial Chemotherapy, vol.67, issue.7, pp.1597-606, 2012.
DOI : 10.1093/jac/dks121

URL : http://jac.oxfordjournals.org/cgi/content/short/67/7/1597

R. Gauzit, Y. Pean, S. Alfandari, J. Bru, J. Bedos et al., Carbapenem use in French hospitals: A nationwide survey at the patient level, International Journal of Antimicrobial Agents, vol.46, issue.6, pp.707-719, 2015.
DOI : 10.1016/j.ijantimicag.2015.08.013

URL : https://hal.archives-ouvertes.fr/hal-01217126

B. Miller and S. Johnson, Demographic and infection characteristics of patients with carbapenem-resistant Enterobacteriaceae in a community hospital: Development of a bedside clinical score for risk assessment, American Journal of Infection Control, vol.44, issue.2, pp.134-141, 2016.
DOI : 10.1016/j.ajic.2015.09.006

F. Zimmerman, M. Assous, T. Bdolah-abram, T. Lachish, and A. Yinnon, Duration of carriage of carbapenem-resistant Enterobacteriaceae following hospital discharge, American Journal of Infection Control, vol.41, issue.3, pp.190-194, 2013.
DOI : 10.1016/j.ajic.2012.09.020

T. Walsh, J. Weeks, D. Livermore, and M. Toleman, Dissemination of NDM-1 positive bacteria in the New Delhi environment and its implications for human health: an environmental point prevalence study, The Lancet Infectious Diseases, vol.11, issue.5, pp.355-62, 2011.
DOI : 10.1016/S1473-3099(11)70059-7

E. Ruppé, L. Armand-lefèvre, C. Estellat, A. El-mniai, Y. Boussadia et al., Acquisition of carbapenemase-producing Enterobacteriaceae by healthy travellers, Euro Surveill Bull Eur Sur Mal Transm Eur Commun Dis Bull, vol.19, issue.14, 2012.

B. Rasmussen, K. Bush, D. Keeney, Y. Yang, R. Hare et al., Characterization of IMI-1 beta-lactamase, a class A carbapenem-hydrolyzing enzyme from Enterobacter cloacae, Antimicrob Agents Chemother. sept, vol.40, issue.9, pp.2080-2086, 1996.

E. Ruppé, L. Armand-lefèvre, C. Estellat, P. Consigny, E. Mniai et al., High Rate of Acquisition but Short Duration of Carriage of Multidrug-Resistant Enterobacteriaceae After Travel to the Tropics, Clinical Infectious Diseases, vol.61, issue.4, pp.593-600, 2015.
DOI : 10.1093/cid/civ333

B. Albiger, C. Glasner, M. Struelens, H. Grundmann, and D. Monnet, European Survey of Carbapenemase-Producing Enterobacteriaceae (EuSCAPE) working group. Carbapenemaseproducing Enterobacteriaceae in Europe: assessment by national experts from 38 countries, Euro Surveill Bull Eur Sur Mal Transm Eur Commun Dis Bull, vol.20, issue.45, 2015.

J. Allyn, M. Angue, O. Belmonte, N. Lugagne, N. Traversier et al., Delayed Diagnosis of High Drug???Resistant Microorganisms Carriage in Repatriated Patients: Three Cases in a French Intensive Care Unit: Table 1, Journal of Travel Medicine, vol.22, issue.3, pp.215-222, 2015.
DOI : 10.1111/jtm.12194

G. Birgand, L. Moore, C. Bourigault, V. Vella, D. Lepelletier et al., Measures to eradicate multidrug-resistant organism outbreaks: how much do they cost?, Clinical Microbiology and Infection, vol.22, issue.2, pp.162-163, 2016.
DOI : 10.1016/j.cmi.2015.10.001

URL : http://dx.doi.org/10.1016/j.cmi.2015.10.001

A. Daroukh, C. Delaunay, S. Bigot, J. Ceci, N. Siddhoun et al., Characteristics and costs of carbapenemase-producing enterobacteria carriers (2012/2013), M??decine et Maladies Infectieuses, vol.44, issue.7, pp.321-327, 2012.
DOI : 10.1016/j.medmal.2014.06.004

L. Saidel-odes, H. Polachek, N. Peled, K. Riesenberg, F. Schlaeffer et al., Conclusions., Infection Control & Hospital Epidemiology, vol.46, issue.01, pp.14-23, 2012.
DOI : 10.1097/QCO.0b013e32833ae214

P. Prasad, J. Sun, R. Danner, and C. Natanson, Excess Deaths Associated With Tigecycline After Approval Based on Noninferiority Trials, Clinical Infectious Diseases, vol.54, issue.12, pp.1699-709, 2012.
DOI : 10.1093/cid/cis270

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3404716

F. Shen, Q. Han, D. Xie, M. Fang, H. Zeng et al., Efficacy and safety of tigecycline for the treatment of severe infectious diseases: an updated meta-analysis of RCTs, International Journal of Infectious Diseases, vol.39, pp.25-33, 2015.
DOI : 10.1016/j.ijid.2015.08.009